BCG vaccination scar associated with better childhood survival in Guinea-Bissau

International Journal of Epidemiology

Volumn 34, Issue 3, 2005, Pages 540-547

  Roth, Adam ^a,b   Gustafson, Per ^a,c   Nhaga, Alexandro ^a   Djana, Queba ^a   Poulsen, Anja ^b   Garly, May Lill ^b   Jensen, Henrik ^a,b   Sodemann, Morten ^a,b   Rodriques, Amabelia ^a   Aaby, Peter ^a,b  

^a BANDIM HEALTH PROJECT   (Guinea-Bissau)

^b DEPARTMENT OF EPIDEMIOLOGY RESEARCH   (Denmark)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

BCG; Cause of death; Infant mortality; Non specific effects of vaccines; Verbal autopsy

Indexed keywords

BCG VACCINE; MEASLES VACCINE;

CAUSE OF DEATH; CHILD HEALTH; MORTALITY RISK; VACCINATION;

ACUTE DIARRHEA; ARTICLE; AUTOPSY; BCG VACCINATION; CAUSE OF DEATH; CHILDHOOD MORTALITY; CHRONIC DIARRHEA; COHORT ANALYSIS; CONTROLLED STUDY; ENCEPHALITIS; FEMALE; GUINEA-BISSAU; HEALTH SURVEY; HOUSEHOLD; HUMAN; IMMUNE RESPONSE; INFANT; MAJOR CLINICAL STUDY; MALARIA; MALE; MENINGITIS; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK REDUCTION; STATISTICAL ANALYSIS; SURVIVAL;

BCG VACCINE; CAUSE OF DEATH; CHILD MORTALITY; CHILD, PRESCHOOL; CICATRIX; COHORT STUDIES; FEMALE; GUINEA-BISSAU; HUMANS; INFANT; INFANT MORTALITY; MALE; REGRESSION ANALYSIS; TUBERCULOSIS;

AFRICA; EASTERN HEMISPHERE; GUINEA-BISSAU; SUB-SAHARAN AFRICA; WEST AFRICA; WORLD;

EID: 20744438949     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/dyh392     Document Type: Article

References (41)

1. Clarke A, Rudd P. Neonatal BCG immunisation. Arch Dis Child 1992;67:473-74.
2. Houston S, Fanning A, Soskolne CL, Fraser N. The effectiveness of bacillus Calmette-Guerin (BCG) vaccination against tuberculosis. A case-control study in Treaty Indians, Alberta, Canada. Am J Epidemiol 1990;131:340-48.
3. Price JF. BCG vaccination. Arch Dis Child 1982;57: 485-86.
4. Tidjani O, Amedome A, ten Dam HG. The protective effect of BCG vaccination of the newborn against childhood tuberculosis in an African community. Tubercle 1986;67:269-81.
5. Colditz GA, Berkey CS, Mosteller F et al. The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics 1995;96: 29-35.
6. ten Dam HG, Hitze KL. Does BCG vaccination protect the newborn and young infants? Bull World Health Organ 1980;58: 37-41.
7. Levine MI, Sackett MF. Results of BCG immunization in New York city. Am Rev Tuberc 1946;53:517-32.
8. Kabir Z. Is all-cause mortality a useful epidemiological endpoint in vaccine trials? An example of BCG (Bacille-Calmette-Guerine). Int J Epidemiol 2003;32:161-65.
9. Kristensen I, Aaby P, Jensen H. Routine immunizations and child survival in Guinea-Bissau, West-Africa. BMJ 2000; 321:1435-38.
10. Niobey FM, Duchiade MP, Vasconcelos AG, de Carvalho ML, Leal MC, Valente JG. [Risk factors for death caused by pneumonia in children younger than 1 year old in a metropolitan region of southeastern Brazil. A case-control study.] Rev Saude Publica 1992;26:229-38.
11. Velema JP, Alihonou EM, Gandaho T, Hounye FH. Childhood mortality among users and non-users of primary health care in a rural west African community. Int J Epidemiol 1991;20:474-79.
12. Fine PEM, Ponnighaus JM, Maine N. The distribution and implications of BCG scars in northern Malawi. Bull World Health Organ 1989;67:35-42.
13. Floyd S, Ponnighaus JM, Bliss L et al. BCG scars in northern Malawi: sensitivity and repeatability of scar reading, and factors affecting scar size. Int J Tuberc Lung Dis 2000; 4:1133-42.
14. Rani SH, Vijayalakshmi V, Sunil K, Lakshmi KA, Suman LG, Murthy KJ. Cell mediated immunity in children with scar-failure following BCG vaccination. Indian Pediatr 1998;35:123-27.
15. Santosa G, Syamsuri MM, Gusti I et al. Difference in severity of tuberculosis in children with or without a BCG scar. Paediatr Indones 1985;25:87-92.
16. Sterne JA, Fine PE, Ponnighaus JM, Sibanda F, Munthali M, Glynn JR. Does bacille Calmette-Guerin scar size have implications for protection against tuberculosis or leprosy? Tuber Lung Dis 1996; 77:117-23.
17. Jason J, Archibald LK, Nwanyanwu OC et al. Clinical and Immune Impact of Mycobacterium bovis BCG Vaccination Scarring. Infect Immun 2002;70:6188-95.
18. Edwards LB, Palmer CE, Magnus K. BCG vaccination. WHO Monograph Series 1953;12.
19. ten Dam HG. Research on BCG vaccination. Adv Tuberc Res 1984;21:79-106.
20. Garly ML, Martins CL, Bale C et al. BCG scar and positive tuberculin reaction associated with reduced child mortality in West-Africa. A non-specific beneficial effect of BCG? Vaccine 2003;21: 2782-90.
21. Marchant A, Goetghebuer T, Ota MO et al. Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guerin vaccination. J Immunol 1999;163:2249-55.
22. Aaby P, Shaheen S, Heyes C et al. Early BCG vaccination and reduction in atopy in Guinea-Bissau. Clin Exp Allergy 2000; 30:644-50.
23. Garly ML, Bale C, Martins CL et al. BCG vaccination among West African infants is associated with less anergy to tuberculin and diphtheria-tetanus antigens. Vaccine 2001;20:468-74.
24. Ota MO, Vekemans J, Schlegel-Haueter SE et al. Influence of Mycobacterium bovis Bacillus Calmette-Guérin on Antibody and Cytokine Responses to Human Neonatal Vaccination. J Immunol 2002;168:919-25.
25. Aaby P. Bandim: An Unplanned Longitudinal Study. In: Gupta MD, Aaby P, Garenne M, Pison G (eds). Prospective Community Studies in Developing Countries. Oxford: Clarendon Press, 1997, pp. 277-96.
26. Gustafson P, Gomes VF, Vieira CS et al. Tuberculosis in Bissau: incidence and risk factors in an urban community in sub-Saharan Africa. Int J Epidemiol 2004;33:163-72.
27. Enarson DA, Rieder HL, Arnadottir T, Trébucq A. Management of tuberculosis. A guide for low income countries. (5th edn). Paris: International Union Against Tuberculosis and Lung Disease, 2000.
28. Anker M, Black RE, Coldham C et al. A Standard Verbal Autopsy Method for Investigating Causes of Death in Infants and Children. WHO, 2002.
29. Molbak K, Aaby P, Ingholt L et al. Persistent and acute diarrhoea as the leading causes of child mortality in urban Guinea Bissau. Trans R Soc Trop Med Hyg 1992;86:216-20.
30. Sodemann M, Jakobsen MS, Molbak K, Alvarenga IC, Jr, Aaby P. High mortality despite good care-seeking behaviour: a community study of childhood deaths in Guinea-Bissau. Bull World Health Organ 1997; 75:205-12.
31. Prentice RL, Kalbfleisch JD, Peterson AV, Jr, Flournoy N, Farewell VT, Breslow NE. The analysis of failure times in the presence of competing risks. Biometrics 1978;34:541-54.
32. Rao MR, Levine RJ, Wasif NK, Clemens JD. Reliability of maternal recall and reporting of child births and deaths in rural Egypt. Paediatr Perinat Epidemiol 2003;17:125-31.
33. Chandramohan D, Setel P, Quigley M. Effect of misclassification of causes of death in verbal autopsy: can it be adjusted? Int J Epidemiol 2001;30:509-14.
34. Veirum JE, Sodemann M, Biai S et al. Diphtheria-tetanus-pertussis and measles vaccinations associated with divergent effects on female and male mortality at the paediatric ward in Bissau, Guinea-Bissau. Vaccine 2004; (in press).
35. Anonymous. BCG vaccination and pediatric HIV infection - Rwanda, 1988-1990. MMWR 1991;40:833-36.
36. Ota MO, O'Donovan D, Marchant A et al. HIV-negative infants born to HIV-1 but not HIV-2-positive mothers fail to develop a Bacillus Calmette-Guerin scar. AIDS 1999;13:996-98.
37. Poulsen AG, Kvinesdal B, Aaby P. Prevalence of and mortality from human immunodeficiency virus type 2 in Bissau, West Africa. Lancet 1989;1:827-31.
38. Larsen O, da Silva Z, Sandstrom A et al. Declining HIV-2 prevalence and incidence among men in a community study from Guinea-Bissau. AIDS 1998;12:1707-14.
39. Adjorlolo-Johnson G, De Cock KM, Ekpini E et al. Prospective comparison of mother-to-child transimission of HIV-A and HIV-2 in Abidjan, Ivory Coast. JAMA 1994;272:462-66.
40. Prazuck T, Yameogo JM, Heylinck B et al. Mother-to-child transmission of human immunodeficiency virus type 1 and type 2 and dual infection: a cohort study in Banfora, Burkina Faso. Pediatr Infect Dis J 1995;14:940-47.
41. Roth A, Jensen H, Garly M, Lisse IM, Sodemann M, Aaby P. Low birth weight infants and Calmette-Guerin bacillus vaccination at birth: community study from Guinea-Bissau. Pediatr Infect Dis J 2004; 23:544-50.